Clinicoprognostic Study of Hydroa Vacciniforme-like Lymphoproliferative Diseases: A Systematic Review.
Kim YJ, Yang HJ, Won CH, Chang SE, Lee MW, Lee WJ.
Dermatology. 2023;239(5):700-711. doi: 10.1159/000530607. Epub 2023 May 25.
PMID:37231869
Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
Iwatsuki K, Miyake T, Hirai Y, Yamamoto T.
Eur J Dermatol. 2019 Feb 1;29(1):21-28. doi: 10.1684/ejd.2018.3490.
PMID:30998212
Deciphering hydroa vacciniforme.
Quintanilla-Martinez L, Fend F.
Blood. 2019 Jun 27;133(26):2735-2737. doi: 10.1182/blood.2019001031.
PMID:31248873
Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection.
Chen CC, Chang KC, Medeiros LJ, Lee JY.
Int J Mol Sci. 2020 Dec 7;21(23):9314. doi: 10.3390/ijms21239314.
PMID:33297336
Hydroa vacciniforme-like lymphoma.
Qiao J, Fang H.
QJM. 2016 Oct;109(10):697-698. doi: 10.1093/qjmed/hcw137. Epub 2016 Aug 9.
PMID:27507019
Hydroa vacciniforme.
Balestri R, Neri I.
CMAJ. 2010 Nov 23;182(17):E796. doi: 10.1503/cmaj.092088. Epub 2010 Sep 13.
PMID:20837686
Youth With Hydroa Vacciniforme.
Ge LY, Liu ZH.
J Cutan Med Surg. 2025 Apr 17:12034754251335841. doi: 10.1177/12034754251335841. Online ahead of print.